Work

Supplementary Figure 3 from ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 50K, Supplementary Figure 3. MK-8776 and VE821 fail to inhibit Chk1 phosphorylation induced by a wide range of cisplatin concentrations.

DOI: 10.1158/0008-5472.22396680

Authors: Catherine J. Huntoon, Karen S. Flatten, Andrea E. Wahner Hendrickson, Amelia M. Huehls, Shari L. Sutor, Scott H. Kaufmann, Larry M. Karnitz

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361259304

Cites:

Cited by:

Related to: 10